Immunic, Inc. (NASDAQ:IMUX) is one of the 11 Best High Volume Penny Stocks to Buy Now. On March 10, 2026, Immunic, Inc. (NASDAQ:IMUX) announced that the European Patent Office granted a key patent covering label-relevant dosing regimens for its lead asset, vidofludimus calcium. The patent is expected to protect Europe through 2038 and may be eligible for a Supplementary Protection Certificate, which could extend exclusivity to as late as 2043. Immunic, Inc. (NASDAQ:IMUX) noted that the claims broadly cov ...